D.C.People moves
Greenberg Traurig hires FDA counsel Gail Javitt from Hyman Phelps in D.C.
Greenberg Traurig hired Gail Javitt as a Washington, D.C., shareholder in its health care and FDA practice from Hyman, Phelps & McNamara, Bloomberg Law reported on October 1, 2026. Javitt advises medical device, diagnostics, pharmaceutical, biologic, and tissue-product companies on trials, approvals, post-market compliance, and laboratory-developed tests.
Announcement (Bloomberg Law) →
Key points
- Gail Javitt joined Greenberg Traurig as a D.C. shareholder in health care and FDA.Bloomberg Law
- She moved from FDA boutique Hyman, Phelps & McNamara.Bloomberg Law
- Her practice covers devices, diagnostics, drugs, biologics, and human cellular and tissue products.Bloomberg Law
- Work includes clinical trials, product approvals, inspections, enforcement, and regulatory designations.Bloomberg Law
- She also advises clinical labs and genomic interpretation companies on laboratory-developed tests.Bloomberg Law